• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    IKE Tech Files First-Ever PMTA for Standalone Interoperable Blockchain-based Age-Gating System at Point of Use - Marking a New Chapter in Youth Vaping Prevention

    5/1/25 8:00:00 AM ET
    $ISPR
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $ISPR alert in real time by email
    • IKE Tech harnesses blockchain technology for real-time identity and age verification to tackle underage vaping in the US
    • Human Factors validation study unveiled 100% effectiveness in age-gating with IKE's BLE Chip
    • Compatible with all ENDS devices, IKE is leading the way toward a safer, more secure future for the ENDS industry

    LOS ANGELES, May 1, 2025 /PRNewswire/ -- IKE Tech LLC ("IKE Tech"), a leading innovator in the intersection of Internet of Things (IoT), identity verification (IDV) and tokenization technology, announced today that it has filed a component Premarket Tobacco Product Application (PMTA) and Tobacco Product Master File (TPMF) with the US Food and Drug Administration (FDA) for its blockchain-based Bluetooth Low Energy (BLE) System-on-a-Chip with the smartphone-enabled identity and age-verification IKE Mobile Application.

    This marks the first ever complete PMTA submission for a standalone, scalable age-gating component that provides real-time continuous age verification at the point-of-use for electronic nicotine delivery systems (ENDS). The IKE System is designed for universal integration across all ENDS devices, utilizing unique blockchain-based tokenization technology to further ensure user privacy and security.

    According to a multi-center Human Factors Validation Study submitted as part of the PMTA, the IKE system proved to be 100% effective in preventing device activation for anyone under the age of 21. The company has formally requested expedited review of its application, emphasizing the system's potential to enhance public health.

    "This is a major milestone for IKE Tech and the ENDS category", commented John Patterson, President of IKE Tech. "We're not just building technology. We're paving a new regulatory framework that gives the FDA and manufacturers powerful tools to safeguard public health and ensure adult-only access to vaping products. With proven, scalable age-gating technology built into ENDS devices, the sector now has a real opportunity to eliminate underage vaping for good".

    One chip, every device: unlocking new era of vaping

    IKE Tech adopted a rigorous software development lifecycle, following consultation with the FDA. The IKE platform offers a seamless identity and age verification experience via a single, user-friendly mobile app available on iOS and Android. By leveraging blockchain technology, it securely validates user's identity and age through integrated identity verification (IDV) partners, anchoring credentials to a tokenization system without storing sensitive data on user's device, nor on IKE's system, to ensure complete user privacy and security.

    Unlike existing solutions that allow permanent access after a single verification, IKE's system requires continuous verification to maintain device access. Human Factors Validation study showed 91% of users (aged 18 – 67) rated the app as "Extremely Easy" or "Very Easy" to use - with a user error rate of less than 0.8% - proving its appeal to the wider market.

    "This is a pivotal moment from a regulatory perspective," said Kevin Burd, CEO of Chemular. By embedding robust age verification at the point of use, the IKE technology enables manufacturers and regulators to confidently allow access to a broader range of products for verified adults. This approach opens the doors for responsible flavor pathways, empowering adult consumers with more choice, while maintaining the highest levels of youth protection."

    Building Smarter and Better ENDS

    IKE Tech is dedicated to building a better, more secure future for all. To meet the evolving needs of manufacturers, the company is planning to continue integrating advanced features like counterfeit protection, geofencing, targeted messaging, and real-time data access to its systems.

    These innovations are designed to address underage vaping and combat the illicit market, ensuring that only products that FDA has determined are Appropriate for the Protection of Public Health (APPH) are available to adult users.

    To learn more about IKE Tech, visit www.iketech.com.

    Notes to Editors:

    Human Factors Study Design and Key Results

    Conducted with 102 participants (51% male, 49% female, aged 18–67 across race/ethnic demographics), the study simulated real-world use of the IKE system. Participants downloaded the app, verified their age, paired with a test device and interacted with BLE-based access controls including biometric reactivation.

    Key performance highlights:

    • 100% of users (n=101) successfully completed age verification
    • 0% of underage users were able to activate a device
    • 100% of devices deactivated after set period of inactivity or loss of Bluetooth signal
    • 91% rated the app "Extremely Easy" or "Very Easy" to use
    • Errors occurred in only 1% of task attempts

    Devices could only be reactivated with biometric authentication. Demographic data (age, race/ethnicity, gender) was accurately verified in all cases. The results confirm the IKE System's ability to reduce user error, prevent underage access, and provide a user-friendly experience for adults.

    About IKE Tech

    IKE Tech LLC ("IKE Tech") is pioneering real-time age and identity verification at the point of use, helping to safeguard access to age-restricted products.

    A leading innovator at the intersection of Internet of Things (IoT), identity verification (IDV), and tokenization technology, IKE Tech has developed an industry-first, scalable age-gating component that provides continuous, real-time verification for electronic nicotine delivery systems (ENDS) and other restricted consumer products.

    IKE Tech's interoperable Bluetooth Low Energy (BLE) System-on-a-Chip, powered by a user-friendly mobile app available on iOS and Android, integrates seamlessly into ENDS devices, giving manufacturers and regulators a flexible, future-proofed solution to combat underage vaping and illicit markets. By setting the new standard for responsible, adult-only access, IKE Tech is helping eliminate youth vaping for good.

    Cision View original content:https://www.prnewswire.com/news-releases/ike-tech-files-first-ever-pmta-for-standalone-interoperable-blockchain-based-age-gating-system-at-point-of-use---marking-a-new-chapter-in-youth-vaping-prevention-302443438.html

    SOURCE IKE Tech LLC

    Get the next $ISPR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ISPR

    DatePrice TargetRatingAnalyst
    5/20/2024$11.00Buy
    ROTH MKM
    More analyst ratings

    $ISPR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ROTH MKM initiated coverage on Ispire Technology with a new price target

      ROTH MKM initiated coverage of Ispire Technology with a rating of Buy and set a new price target of $11.00

      5/20/24 7:18:59 AM ET
      $ISPR
      Medicinal Chemicals and Botanical Products
      Health Care

    $ISPR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Ispire Technology Inc.

      SC 13G - Ispire Technology Inc. (0001948455) (Subject)

      7/12/24 5:00:02 PM ET
      $ISPR
      Medicinal Chemicals and Botanical Products
      Health Care

    $ISPR
    Leadership Updates

    Live Leadership Updates

    See more
    • Ispire Technology Inc. Announces Appointment of Jay Yu as Chief Financial Officer

      Jie "Jay" Yu has a strong track record of excellence in public company accounting, and has served in the role of Vice President of Finance for Ispire since June 2023 Ispire also further streamlines operations by cutting an estimated $3.6 million in annual payroll in May 2025 Ispire expects to also cut up to an additional $6.6 million in annual operating expenses over the next three months, for a total estimated annualized expense reduction of $10.2 million LOS ANGELES, May 15, 2025 /PRNewswire/ -- Ispire Technology Inc. (NASDAQ:ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today announced the appointment of Jie "Jay" Yu as the

      5/15/25 4:30:00 PM ET
      $ISPR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Ispire Technology Inc. Announces Key Leadership Appointments

      LOS ANGELES, Aug. 14, 2023 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or "the Company") (NASDAQ:ISPR), a leader in vapor technology, providing high-quality, innovative products with first-class performance, announced today the appointment of Michael Wang as its Co-Chief Executive Officer.  Mr. Wang previously served as Chief Financial Officer. Concurrently, Daniel J. Machock was appointed as the new Chief Financial Officer. Mr. Wang has assumed the role of Co-Chief Executive Officer alongside Tuanfang Liu, as Co-Chief Executive Officer. This strengthened leadership structure is designed to refine Ispire's strategic direction and spearhead the Company's future growth. Ispire's decision

      8/14/23 8:35:00 AM ET
      $ISPR
      Medicinal Chemicals and Botanical Products
      Health Care

    $ISPR
    Financials

    Live finance-specific insights

    See more
    • Ispire Technology Inc. Reports Financial Results for Fiscal Third Quarter 2025

      Accounts Receivable Decreased from $67.7M to $60.4M Improving Company Financial PositionPost-Quarter End, IKE Tech Filed PMTA with the FDA for its Age-Gating Joint Venture Component with IKELaunched SproutTM in Collaboration with Raw Garden, an Advanced All-In-One Cannabis Vapor Device Ensuring Purity and Safety  LOS ANGELES, May 12, 2025 /PRNewswire/ -- Ispire Technology Inc. (NASDAQ:ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today reported financial results for the third quarter of fiscal 2025, for the three months ending March 31, 2025. Fiscal Third Quarter 2025 Financial Results Revenue of $26.2 million versus $30.0 mil

      5/12/25 7:00:00 AM ET
      $ISPR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Ispire Technologies Inc. Schedules Fiscal Third Quarter 2025 Earnings Conference Call

      LOS ANGELAS, May 7, 2025 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ:ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will host its earnings conference call at 8:00am ET on Monday, May 12, 2025, to discuss the Company's financial results for the fiscal third quarter ended March 31, 2025. To listen to the conference call, please dial in using the information below. When prompted upon dialing-in, please ask for the "Ispire Technology Call." Date: Monday, May 12, 2025Time: 8:00am ETDial-In Numbers: North America 888-880-3330 or International +1 646-357-8766This conference call will be webcast live and can be accessed by all

      5/7/25 4:30:00 PM ET
      $ISPR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Ispire Technology Inc. to Participate in Webull Corporate Webinar Series on February 18, 2025

      LOS ANGELES, Feb. 12, 2025 /PRNewswire/ -- Ispire Technology Inc. (NASDAQ:ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today announced that Michael Wang, Co-Chief Executive Officer, will present at the Webull Consumer Webinar Series: Consumer, on February 18, 2025. Conference Details: Webull Corporate Webinar Series - ConsumerDate/Time: Tuesday, February 18th at approximately 3:00 p.m. ETPresenter: Michael Wang, Co-CEORegistration Link: HERERecent Highlights: 2/10/25: Ispire Technology Inc. Reports Financial Results for Fiscal Second Quarter 2025 1/22/25: Ispire Technology Inc. Announces Stock Repurchase Program 1/15/25: Ispi

      2/12/25 8:00:00 AM ET
      $ISPR
      Medicinal Chemicals and Botanical Products
      Health Care

    $ISPR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CLO and Secretary Pryzbyla Steven P. sold $1,785 worth of shares (500 units at $3.57), decreasing direct ownership by 0.12% to 416,710 units (SEC Form 4)

      4 - Ispire Technology Inc. (0001948455) (Issuer)

      3/19/25 4:30:15 PM ET
      $ISPR
      Medicinal Chemicals and Botanical Products
      Health Care
    • CLO and Secretary Pryzbyla Steven P. sold $24,982 worth of shares (6,200 units at $4.03), decreasing direct ownership by 1% to 417,210 units (SEC Form 4)

      4 - Ispire Technology Inc. (0001948455) (Issuer)

      3/14/25 4:30:05 PM ET
      $ISPR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Cox Brent was granted 8,077 shares, increasing direct ownership by 63% to 20,998 units (SEC Form 4)

      4 - Ispire Technology Inc. (0001948455) (Issuer)

      1/10/25 6:05:19 AM ET
      $ISPR
      Medicinal Chemicals and Botanical Products
      Health Care

    $ISPR
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $ISPR
    SEC Filings

    See more
    • Ispire Technology Inc. Announces Approval of Interim License for Manufacturing of Nicotine Products in Malaysia

      Interim License Approved in May, with Authority to Begin Manufacturing of Nicotine Products in Malaysia Immediately LOS ANGELES, May 22, 2025 /PRNewswire/ -- Ispire Technology Inc. (NASDAQ:ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today announced it has received the interim license from the Malaysian Government for the manufacturing of nicotine products. This is the first and only nicotine manufacturing license issued in Malaysia approved by both the Federal and State authorities and cements Ispire's position as the only company with full authorization for export, import, and production. The approval of the interim license

      5/22/25 9:00:00 AM ET
      $ISPR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Ispire Technology Inc. Announces Appointment of Jay Yu as Chief Financial Officer

      Jie "Jay" Yu has a strong track record of excellence in public company accounting, and has served in the role of Vice President of Finance for Ispire since June 2023 Ispire also further streamlines operations by cutting an estimated $3.6 million in annual payroll in May 2025 Ispire expects to also cut up to an additional $6.6 million in annual operating expenses over the next three months, for a total estimated annualized expense reduction of $10.2 million LOS ANGELES, May 15, 2025 /PRNewswire/ -- Ispire Technology Inc. (NASDAQ:ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today announced the appointment of Jie "Jay" Yu as the

      5/15/25 4:30:00 PM ET
      $ISPR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Ispire Technology Inc. Reports Financial Results for Fiscal Third Quarter 2025

      Accounts Receivable Decreased from $67.7M to $60.4M Improving Company Financial PositionPost-Quarter End, IKE Tech Filed PMTA with the FDA for its Age-Gating Joint Venture Component with IKELaunched SproutTM in Collaboration with Raw Garden, an Advanced All-In-One Cannabis Vapor Device Ensuring Purity and Safety  LOS ANGELES, May 12, 2025 /PRNewswire/ -- Ispire Technology Inc. (NASDAQ:ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today reported financial results for the third quarter of fiscal 2025, for the three months ending March 31, 2025. Fiscal Third Quarter 2025 Financial Results Revenue of $26.2 million versus $30.0 mil

      5/12/25 7:00:00 AM ET
      $ISPR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Ispire Technology Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Ispire Technology Inc. (0001948455) (Filer)

      5/23/25 4:30:34 PM ET
      $ISPR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Ispire Technology Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - Ispire Technology Inc. (0001948455) (Filer)

      5/15/25 4:30:11 PM ET
      $ISPR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Ispire Technology Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Ispire Technology Inc. (0001948455) (Filer)

      5/12/25 7:00:13 AM ET
      $ISPR
      Medicinal Chemicals and Botanical Products
      Health Care